Pediatric rheumatology

Journal articles and book chapters

13-04-2018 | Juvenile idiopathic arthritis | Article

Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial

Opoka-Winiarska V et al. Clin Rheumatol 2018; Advance online publication. doi: 10.1007/s10067-018-4071-9

11-04-2018 | Juvenile idiopathic arthritis | Article

Treating juvenile idiopathic arthritis to target: recommendations of an international task force

Ravelli A et al. Ann Rheum Dis 2018; Advance online publication. doi: 10.1136/annrheumdis-2018-213030

10-04-2018 | Pediatric | Article

Amendment of the OMERACT ultrasound definitions of joints’ features in healthy children when using the DOPPLER technique

Collado P et al. Pediatr Rheumatol 2018; 16: 23. doi: 10.1186/s12969-018-0240-2

07-04-2018 | Juvenile idiopathic arthritis | Article

Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: Review of the general methodology

Bovis F et al. Rheumatol Int 2018; 38(Suppl 1): 5–17. doi: 10.1007/s00296-018-3944-1

05-04-2018 | Juvenile idiopathic arthritis | Article

IL-6 blockade in systemic juvenile idiopathic arthritis: Achievement of inactive disease and remission (data from the German AID-registry)

Bielak M et al. Pediatr Rheumatol 2018; 16: 22. doi: 10.1186/s12969-018-0236-y

28-03-2018 | Juvenile idiopathic arthritis | Article

Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: The SHARE initiative

Constantin T et al. Ann Rheum Dis 2018; Advance online publication. doi: 10.1136/annrheumdis-2018-213131

21-03-2018 | Pathogenesis | Review | Article

Type I interferon in rheumatic diseases

Wampler TL, Niewold TB. Nat Rev Rheumatol 2018; 14: 214–228. doi: 10.1038/nrrheum.2018.31

02-03-2018 | Tocilizumab | Review | Article

A review of recent advances using tocilizumab in the treatment of rheumatic diseases

Rubbert-Roth A et al. Rheumatol Ther 2018; Advance online publication. doi: 10.1007/s40744-018-0102-x

27-02-2018 | Juvenile idiopathic arthritis | Article

A phase II trial protocol of tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)

Ramanan AV et al. BMC Rheumatol 2018; 2: 4. doi: 10.1186/s41927-018-0010-2

26-02-2018 | Juvenile idiopathic arthritis | Patient and physician’s perspective | Article

Living with juvenile idiopathic arthritis: Parent and physician perspectives

This article, co-authored by a parent of a child with juvenile idiopathic arthritis and his pediatric rheumatologist, discusses the parent’s experience from diagnosis through living day-to-day with the disease.

Heath-Watson S, Sule S. Rheumatol Ther 2018; Advance online publication. doi: 10.1007/s40744-018-0098-2

20-02-2018 | Mental health | Review | Article

Addressing mental health in pediatric rheumatology

Rubinstein TB et al. Curr Treat Options in Rheum 2018 4: 55–72. doi: 10.1007/s40674-018-0092-4

09-02-2018 | Kawasaki disease | Article

The association between oxidative stress and endothelial dysfunction in early childhood patients with Kawasaki disease

Ishikawa T, Seki K. BMC Cardiovasc Disord 2018; 18: 30. doi: 10.1186/s12872-018-0765-9

08-02-2018 | Juvenile idiopathic arthritis | Article

Association of interferon regulatory factor 5 (IRF5) gene polymorphisms with juvenile idiopathic arthritis

Esmaeili Reykande S et al. iClin Rheumatol 2018; Advance online publication. doi: 10.1007/s10067-018-4010-9

08-02-2018 | Juvenile idiopathic arthritis | Review | Article

Treat to target in juvenile idiopathic arthritis: Challenges and opportunities

Smitherman EA, Consolaro A, Morgan EM. Curr Treat Options in Rheum 2018; 4: 29–43. doi: 10.1007/s40674-018-0090-6

24-01-2018 | Pathogenesis | Review | Article

Moving towards a molecular taxonomy of autoimmune rheumatic diseases

Barturen G et al. Nat Rev Rheumatol 2018; 14: 75–93. doi: 10.1038/nrrheum.2017.220

24-01-2018 | Juvenile idiopathic arthritis | Article

Defining the normal appearance of the temporomandibular joints by magnetic resonance imaging with contrast: a comparative study of children with and without juvenile idiopathic arthritis

Stoll ML et al. Pediatr Rheumatol 2018; 16: 8. doi: 10.1186/s12969-018-0223-3

16-11-2017 | Juvenile idiopathic arthritis | Review | Article

Update on the treatment of uveitis in patients with juvenile idiopathic arthritis: A review

This review article by Asproudis et al. provides an overview of the treatment of chronic uveitis, a common extra-articular manifestation of juvenile idiopathic arthritis.

Asproudis I et al. Adv Ther 2017;34:2558–2565. doi:10.1007/s12325-017-0635-3

07-08-2017 | Vasculitis | Review | Article

Vasculitis update: Pathogenesis and biomarkers

Brogan & Eleftheriou summarize recent advances in the understanding of the pathophysiology of primary systemic vasculitides and the potential role of novel biomarkers discovered in that context.

Brogan P, Eleftheriou D. Pediatr Nephrol 2017. doi:10.1007/s00467-017-3597-4

04-08-2017 | Juvenile idiopathic arthritis | Review | Article

Ultrasound imaging of synovial inflammation in juvenile idiopathic arthritis

In this review, the authors provide an overview on the use of ultrasound to identify and monitor joint changes in patients with juvenile idiopathic arthritis.

Chauvin NA, Doria AS. Pediatr Radiol 2017;47:1160–1170. doi:10.1007/s00247-017-3934-6

20-07-2017 | Juvenile idiopathic arthritis | Review | Article

Biologics in juvenile idiopathic arthritis: A narrative review

In this review, Vanoni et al. summarize the currently available biologics used in juvenile idiopathic arthritis, highlighting how these have improved outcomes and the quality of life of patients.

Vanoni F, Minoia F, Malattia C. Eur J Pediatr 2017;176:1147–1153. doi:10.1007/s00431-017-2960-6

Next Previous